Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Twist Bioscience Corp TWST

Twist Bioscience Corporation is a synthetic biology and genomics company that has developed a deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company's platform's core is a proprietary technology that develops manufacturing synthetic DNA by writing DNA on a silicon chip. The Company leverages its technology to manufacture a broad range of... see more

Recent & Breaking News (NDAQ:TWST)

Twist Bioscience to Present at the Stifel 2020 Virtual Healthcare Conference

Business Wire November 10, 2020

Twist Bioscience to Report Fiscal 2020 Fourth Quarter and Full Year Financial Results on Monday, November 23, 2020

Business Wire November 2, 2020

Twist Bioscience Showcases Next-Generation Sequencing Presentations at Virtual American Society for Human Genetics 2020 Annual Meeting

Business Wire October 29, 2020

Twist Bioscience Collaborates With Beyond Earth to Launch Artwork Stored in DNA Into Space

Business Wire October 27, 2020

Twist Bioscience to Host Virtual Biopharma Analyst & Investor Event on October 23, 2020

Business Wire October 13, 2020

Twist Bioscience and Neogene Announce Broad Strategic Partnership for Next Generation Personalized T Cell Therapies

Business Wire October 13, 2020

Emily Leproust, Ph.D., to Receive 2020 Rosalind Franklin Award

Business Wire September 18, 2020

Twist Bioscience to Present at Upcoming Virtual Investor Conferences

Business Wire September 3, 2020

Twist Bioscience Announces Potent SARS-CoV-2 Neutralizing Data from COVID-19 Therapeutic Antibody Program

Business Wire September 2, 2020

Twist Bioscience Synthetic DNA Stores New Netflix Original Series 'BIOHACKERS'

Business Wire August 20, 2020

Twist Bioscience Reports Third Quarter Fiscal 2020 Financial Results

Business Wire August 6, 2020

Seismic Bio Partners With Twist Bioscience for Discovery and Optimization of Antibodies

Business Wire August 4, 2020

Twist Bioscience to Report Fiscal 2020 Third Quarter Financial Results on Thursday, August 6, 2020

Business Wire July 30, 2020

Twist Bioscience Launches Two SARS-CoV-2 Antibody Panels to Expedite Research for COVID-19

Business Wire July 28, 2020

Twist Bioscience Appoints Erin Smith Senior Vice President, Government Affairs and Public Policy

Business Wire July 23, 2020

Twist Bioscience Launches Synthetic Controls for Respiratory Viruses

Business Wire July 22, 2020

Twist Bioscience Partners with Invetx to Deliver Best-in-Class Antibody Therapeutics for Dogs and Cats

Business Wire July 16, 2020

Twist Bioscience Customer Vanderbilt University Medical Center (VUMC) Announces Publication of Positive Preclinical Results on Neutralizing Antibodies as a Potential Therapy for Preventing and Treating COVID-19

Business Wire July 15, 2020

Takeda Partners with Twist Bioscience to Expand Biologics Discovery Capabilities

Business Wire July 8, 2020

Twist Bioscience Adds Respiratory Virus Panel to Infectious Disease Product Line

Business Wire June 30, 2020